ACE Technology Guidances

ACE Technology Guidances communicate recommendations from the MOH Drug Advisory Committee or the MOH Medical Technology Advisory Committee on the funding status and appropriate use of drugs, vaccines or medical technologies that have been evaluated by ACE. The guidances also include the Committee’s rationale for the funding recommendations, and key clinical and economic evidence which informed their deliberations. Plain English Summaries (PES) to explain ACE Technology Guidances are available for patients and the public.

Published on 02 Jan 2019
Last Updated on 02 Jan 2019
A- A+
Guidance Recommendation
The Ministry of Health’s MTAC has recommended:
  • Video capsule endoscopy (VCE) as a diagnostic modality for patients with suspected obscure gastrointestinal bleeding (OGIB), in the absence of known or recognised contraindications, after upper and lower GI sources of bleeding have been excluded with negative oesophagogastroduodenoscopy (OGD) and colonoscopy.
VCE should not be used in patients who require immediate intervention, including those with massive haemodynamically unstable bleeding.

Subsidy status
VCE is subsidised for eligible patients when used in line with the abovementioned indication.

VCE for diagnosing obscure gastrointestinal bleeding (2 Jan 2019)